ctrl K

Watchlist Price Alert

Harmony Biosciences Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

33.71

0.32 (0.96%)

At close: May 15, 2025, 10:45 AM

Harmony Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	714.73M	582.02M	437.86M	305.44M	159.74M	6M	n/a
Cost of Revenue	156.81M	121.24M	83.48M	55.52M	27.74M	1.58M	184K
Gross Profit	557.92M	460.79M	354.37M	249.92M	132M	4.42M	-184K
Operating Income	190.83M	192.03M	120.19M	68.7M	3.68M	-145.9M	-41.44M
Interest Income	18.54M	14.73M	3.13M	223K	28.22M	6.07M	n/a
Pretax Income	191.8M	173.4M	104.69M	37.43M	-36.94M	-151.98M	-39.9M
Net Income	145.49M	128.85M	181.47M	34.6M	-51.86M	-158.05M	-39.9M
Selling & General & Admin	221.27M	192.69M	163.3M	132.03M	95.57M	80.73M	29.07M
Research & Development	145.82M	76.06M	70.89M	30.37M	19.45M	69.59M	12.37M
Other Expenses	n/a	n/a	169K	16K	-3.07M	n/a	n/a
Operating Expenses	367.09M	268.76M	234.19M	162.39M	115.02M	150.32M	41.44M
Interest Expense	17.5M	23.76M	15.67M	23.97M	28.22M	6.07M	n/a
Selling & Marketing Expenses	110.92M	97.4M	79.28M	68.12M	55.82M	44.32M	16.86M
Cost & Expenses	523.91M	389.99M	317.67M	217.91M	142.76M	151.9M	41.44M
Income Tax Expense	46.31M	44.54M	-76.78M	2.83M	14.91M	6.07M	1.54M
Shares Outstanding (Basic)	56.89M	59.47M	59.17M	57.53M	56.89M	63.68M	49.24M
Shares Outstanding (Diluted)	57.87M	60.37M	61.1M	59.21M	56.89M	63.68M	49.24M
EPS (Basic)	2.56	2.17	3.07	0.60	-0.91	-2.48	-0.81
EPS (Diluted)	2.51	2.13	2.97	0.58	-0.91	-2.48	-0.81
EBITDA	233.41M	221.51M	143.57M	106.37M	1.51M	-142.69M	-41.26M
EBIT	209.3M	197.15M	120.19M	61.62M	16.99M	-145.9M	-41.44M
Depreciation & Amortization	24.11M	24.36M	23.39M	18.84M	10.24M	3.21M	184K